Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory: 2013-2016

Historic Change in Inventory for Viridian Therapeutics, Inc.\DE (VRDN) over the last 4 years, with Dec 2016 value amounting to -$123,000.

  • Viridian Therapeutics, Inc.\DE's Change in Inventory rose 101.13% to $2,000 in Q4 2016 from the same period last year, while for Dec 2016 it was -$123,000, marking a year-over-year decrease of 1637.50%. This contributed to the annual value of -$123,000 for FY2016, which is 1637.50% down from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Change in Inventory of -$123,000 as of FY2016, which was down 1,637.50% from $8,000 recorded in FY2015.
  • Viridian Therapeutics, Inc.\DE's 5-year Change in Inventory high stood at $187,000 for FY2013, and its period low was -$178,000 during FY2014.
  • Its 3-year average for Change in Inventory is -$97,667, with a median of -$123,000 in 2016.
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Change in Inventory surged by 104.49% in 2015, and later tumbled by 1,637.50% in 2016.
  • Over the past 4 years, Viridian Therapeutics, Inc.\DE's Change in Inventory (Yearly) stood at $187,000 in 2013, then plummeted by 195.19% to -$178,000 in 2014, then surged by 104.49% to $8,000 in 2015, then tumbled by 1,637.50% to -$123,000 in 2016.